Iisrael - heebrea - Ministry of Health

roche pharmaceuticals (israel) ltd - pertuzumab; trastuzumab - תמיסה להזרקה - trastuzumab 40 mg/ml; pertuzumab 80 mg/ml - pertuzumab and trastuzumab

Iisrael - heebrea - Ministry of Health

roche pharmaceuticals (israel) ltd - pertuzumab; trastuzumab - תמיסה להזרקה - trastuzumab 60 mg/ml; pertuzumab 60 mg/ml - pertuzumab and trastuzumab

Iisrael - heebrea - Ministry of Health

novartis israel ltd - lapatinib as ditosylate monohydrate - טבליות מצופות פילם - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting (see section 5.1).• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.

Iisrael - heebrea - Ministry of Health

novartis israel ltd - docetaxel - תרכיז להכנת תמיסה לאינפוזיה - docetaxel 10 mg / 1 ml - docetaxel - docetaxel - breast cancer: docetaxel in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node- positive breast cancer. docetaxel in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition. docetaxel monotherapy is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic therapy. previous chemotherapy should have included an anthracycline or an alkylating agent. docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumors overexpress her2 and who previously have not received chemotherapy for metastatic disease. docetaxel in combination with capecitabine is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic chemotherapy. previous therapy should have included an anthracyclin

Iisrael - heebrea - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - docetaxel - תמיסה לאינפוזיה - docetaxel 10 mg / 1 ml - docetaxel - docetaxel - breast cancer: docetaxel in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node- positive breast cancer. docetaxel in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition. docetaxel monotherapy is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic therapy. previous chemotherapy should have included an anthracycline or an alkylating agent. docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumors overexpress her2 and who previously have not received chemotherapy for metastatic disease. docetaxel in combination with capecitabine is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic chemotherapy. previous therapy should have included an anthracyclin

Iisrael - heebrea - Ministry of Health

roche pharmaceuticals (israel) ltd - pertuzumab - תרכיז להכנת תמיסה לאינפוזיה - pertuzumab 420 mg / 14 ml - pertuzumab - pertuzumab - perjeta is indicated in combination with trastuzumab and docetaxel for the treatment of patients with her2 positive metastatic breast cancer who have not received prior anti-her2 therapy or chemotherapy for metastatic disease.

Iisrael - heebrea - Ministry of Health

promedico ltd - selinexor - טבליה - selinexor 20 mg - selinexor

Iisrael - heebrea - Ministry of Health

takeda israel ltd - ixazomib as citrate - קפסולות - ixazomib as citrate 2.3 mg - ixazomib

Iisrael - heebrea - Ministry of Health

takeda israel ltd - ixazomib as citrate - קפסולות - ixazomib as citrate 2.3 mg - ixazomib

Iisrael - heebrea - Ministry of Health

takeda israel ltd - ixazomib as citrate - קפסולות - ixazomib as citrate 3 mg - ixazomib